Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/1996
10/02/1996EP0734731A2 A multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose
10/02/1996EP0734730A1 Use of a CGRP antagonist for the treatment of ocular or eyelid pruritis and disesthesies
10/02/1996EP0734729A1 Use of a CGRP antagonist for the treatment of cutaneous erythema of neurogenic origin and so obtained composition
10/02/1996EP0734728A1 Use of a CGRP antagonist for the treatment of lichens and pruritis and composition so obtained
10/02/1996EP0734725A2 Adjuvants containing colloidal iron compounds
10/02/1996EP0734721A2 Method of incorporating drugs into a polymer component of stents
10/02/1996EP0734529A1 Methods and materials for the detection of staphylococcus aureus
10/02/1996EP0734526A1 Maleimide adduct conjugates of procainamide and napa
10/02/1996EP0734451A1 ENTEROTOXINS OF $i(SHIGELLA FLEXNERI) 2a
10/02/1996EP0734442A1 Diagnosis of metastatic cancer by the mts-1 gene
10/02/1996EP0734440A1 Tumor cell fusions and methods for use of such tumor cell fusions
10/02/1996EP0734436A1 Inhibition of dna methyltransferase
10/02/1996EP0734263A1 ALPHAvBETA3 INTEGRIN AS A PREDICTOR OF ENDOMETRIOSIS
10/02/1996EP0734251A1 Method of transmitting a biologically active material to a cell
10/02/1996EP0575497B1 Dna sequences which code for virulence characteristics of -$(streptococcus suis) and parts thereof, polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by -$(s. suis) in mammals, including man
10/02/1996EP0502016B1 Novel vaccine
10/02/1996EP0275285B1 Biodegradable superparamagnetic materials used in clinical applications
10/02/1996DE19512142A1 Infektiöser cDNA-Klon des Tick-Borne Enzephalitis (TBE)-Virus, davon abgeleiteter rekombinanter Impfstoff und Herstellung desselben sowie ein pharmazeutisches Produkt, das eine replizierbare Nukleinsäure enthält Infectious cDNA clone of the tick-borne encephalitis (TBE) virus derived therefrom recombinant vaccine and the preparation thereof and a pharmaceutical product containing a replicable nucleic acid
10/02/1996CN1132516A Monoclonal IgA antibody against respiratory syncytial virus
10/02/1996CN1132514A Protective antigens against parasites
10/02/1996CN1132211A Process for purifying hepatitis B viral surface antigen comprising PRES2 peptide
10/01/1996US5561119 Glycosylated prodrugs, their method of preparation and their uses
10/01/1996US5561050 Methods for diagnosis of colon, stomach and pancreatic cancer using antibodies specific for a mucin-type carbohydrate chain
10/01/1996US5561043 Genetic engineering
10/01/1996US5560915 Composition for treating IgE mediated allergies comprising substance P and allergen
10/01/1996US5560914 Immunopotentiator and method of manufacturing the same
10/01/1996CA2172305A1 Multiple antigenic peptide comprising at least two hepatitis c virus-associated peptides
10/01/1996CA1338619C Lectin complex and method and probe for making same
10/01/1996CA1338618C Vaccine adjuvant
09/1996
09/28/1996CA2172685A1 Adjuvant based on colloidal iron compounds
09/26/1996WO1996029605A2 Compounds and methods for the dectection of t. cruzi infection
09/26/1996WO1996029604A1 Method for diagnosing a patient for chlamydia
09/26/1996WO1996029425A1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae
09/26/1996WO1996029421A1 Vectors for gene delivery
09/26/1996WO1996029417A1 Il-13 receptor specific chimeric proteins and uses thereof
09/26/1996WO1996029413A2 Dna encoding human papilloma virus type 18
09/26/1996WO1996029412A1 Proteinase k resistant surface protein of neisseria meningitidis
09/26/1996WO1996029410A1 In vivo generation of antibodies against antigens secreted in a host by transfected mel cells
09/26/1996WO1996029409A2 Rage tumor rejection antigens
09/26/1996WO1996029404A1 HUMAN METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE mGluR6
09/26/1996WO1996029396A1 Recombinant infectious laryngotracheitis virus and uses thereof
09/26/1996WO1996029394A1 Method for treating tumors
09/26/1996WO1996029096A1 Gene transfer preparation
09/26/1996WO1996029094A1 Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents
09/26/1996WO1996029093A1 Tumour cells for use as a tumour vaccine containing at least one antigen for which an immune response already exists
09/26/1996WO1996029091A1 Treatment of papillomavirus-associated lesions using interleukin-12
09/26/1996WO1996029087A1 Methods for reduced renal uptake of antibody fragments
09/26/1996WO1996029084A1 A chinese drug composition for treatment of peptic ulcer and preparation thereof
09/26/1996WO1996021014A3 Production and administration of high titer recombinant retroviruses
09/26/1996WO1996011272A3 Papilloma virus-like particles, fusion proteins and process for producing the same
09/26/1996CA2216139A1 Recombinant infectious laryngotracheitis virus and uses thereof
09/26/1996CA2215730A1 Human metabotropic glutamate receptor subtype mglur6
09/26/1996CA2215525A1 Treatment of papillomavirus-associated lesions using interleukin-12
09/26/1996CA2215162A1 Vectors for gene delivery
09/26/1996CA2215122A1 Il-13 receptor specific chimeric proteins and uses thereof
09/26/1996CA2215104A1 Compounds and methods for the detection of t. cruzi infection
09/26/1996CA2211448A1 Rage tumor rejection antigens
09/25/1996EP0733903A1 Immunoassay for the detection of urinary cortisol and reagents therefor
09/25/1996EP0733708A2 Transferrin-binding protein 1 (Tbp1) gene of Actinobacillus pleuropneumoniae, its use in vaccines for pleuropneumonia and as diagnostic reagents
09/25/1996EP0733643A1 Membrane protein polypeptide having function of supporting pre-b cell growth and gene therefor
09/25/1996EP0733373A2 Compositions and methods for increasing the immunogenicity of tumor cells by administration of B7 and CD2-transfected cells
09/25/1996EP0733114A1 CONSTRUCTION OF $i(PASTEURELLA HEAMOLYTICA) VACCINES
09/25/1996EP0733110A1 Tuberous sclerosis 2 gene and uses thereof
09/25/1996EP0733107A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY
09/25/1996EP0733072A1 Antibody against carcinoembryonic antigen (cea)
09/25/1996EP0733071A1 Antagonists to chaperonin 10
09/25/1996EP0733069A1 Purified primate ctla-8 antigens and related reagents
09/25/1996EP0733066A1 Pretargeting methods and compounds
09/25/1996EP0733065A1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
09/25/1996EP0733064A1 NUCLEIC ACIDS ENCODING A HOUSE DUST MITE ALLERGEN, $i(DER P) III, AND USES THEREFOR
09/25/1996EP0733061A1 Cholesteryl ester transfer protein inhibitor peptides and prophylactic and therapeutic anti-arteriosclerosis agents
09/25/1996EP0732943A1 Three-step pretargeting methods and compounds
09/25/1996EP0732939A1 Preparation and use of immunoconjugates
09/25/1996EP0732938A1 Method of treating intestinal disorders
09/25/1996EP0732937A1 Non-toxic mucosal adjuvant
09/25/1996EP0732936A1 Adjuvant for antigens, process for producing the same and its use
09/25/1996EP0732875A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
09/25/1996EP0587805B1 Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits for detection of bovine herpesvirus type 1
09/25/1996EP0511308B1 Chimeric immunoglobulin for cd4 receptors
09/25/1996EP0432249B1 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore
09/25/1996CN1131556A Weikang capsule for curing gastropathy and its preparation method
09/25/1996CA2172451A1 Process for the immunologic determination of cortisol, especially urinary cortisol, and reagents used
09/25/1996CA2172443A1 Transferrin-binding protein 1 (tbp1) gene of actinobacillus pleuropneumoniae, its use to prepare products for the utilization in vaccines for pleuropneumonia and as diagnostic reagents
09/24/1996USRE35338 Sustained release delivery of water soluble bio-molecules and drugs using phosphokipid-coated microcrystals, microdroplets and high-concentration lipsomes
09/24/1996US5559213 Polyethylene-protein conjugates
09/24/1996US5559028 Methods of enhancing or antigen presentation to T cells inhibiting
09/24/1996US5559012 Monoclonal antibodies detected with cytokines and kits
09/24/1996US5559011 Nucleic acids encoding membrane-associated immunogens of mycobacterial and corresponding probes, vectors, and transformed host cells
09/24/1996US5559008 Dna sequences, codes, gene expression, vectors
09/24/1996US5558995 Peptides which are derived from tumor rejection antigen precursor molecule MAGE-1, which complex to MHC molecule HLA-C clone 10, and uses thereof
09/24/1996US5558993 Genetic engineering; lyme disease vaccine
09/24/1996US5558869 Major peanut allergen ara h II
09/24/1996US5558867 Poultry
09/24/1996US5558864 Humanized and chimeric anti-epidermal growth factor receptor monoclonal antibodies
09/24/1996US5558860 Viral vaccines
09/24/1996CA2172436A1 Compositions and methods for increasing the immunogenicity of tumor cells
09/19/1996WO1996028569A1 Monoclonal antibody and antigen relating to human pulmonary adenocarcinoma and immunoassay method with the use of the same
09/19/1996WO1996028563A1 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy
09/19/1996WO1996028552A1 Rheumatoid arthritis-related virus msrv-1 and pathogenic and/or infective agent msrv-2
09/19/1996WO1996028551A1 Vaccines for plague
1 ... 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 ... 1823